Products Neurology TERIFLUNOMIDE/STADA

TERIFLUNOMIDE/STADA

FORM

Film-coated tablet

STRENGTH

14 mg

INDICATIONS

Teriflunomide/Stada is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (MS)

Important note

The treatment should be initiated and supervised by a physician experienced in the management of multiple sclerosis.